跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 惠亭
副教授
藥學系
電話
(02)2826-7157
電子郵件
htchen1969
nycu.edu
tw
網站
https://pharmacy.ym.edu.tw/ezfiles/284/1284/img/1918/701554848.pdf
h-index
h10-index
h5-index
1616
引文
20
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
320
引文
11
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
35
引文
4
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1998 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(53)
類似的個人檔案
(6)
指紋
查看啟用 Hui-Ting Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Dendrimer
100%
Polyamidoamine (PAMAM)
75%
Solid-phase Synthesis
47%
Hydrolysis
44%
Resin
40%
Melamine
33%
Quinazolin
33%
Calcium Phosphate
29%
Simvastatin
29%
Hydroxyapatite
26%
Percentage Yield
25%
Cytotoxicity
25%
Binding Affinity
25%
Hydroxyapatite Powder
24%
Pyridine
23%
Lysine
23%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
22%
Calcium Hydrogen Phosphate
22%
Chemical nuclease
22%
Crystallization
22%
Biocompatibility
22%
Calcination
22%
Copper Complex
22%
Mesenchymal Stem Cells
22%
Human Mesenchymal Stem Cells (hMSCs)
21%
X Ray Diffraction
18%
Functional Groups
18%
PAMAM Dendrimer
18%
Silica
16%
Low Temperature
16%
Aryl
16%
Iodide
16%
Triazine Dendrimer
16%
Hydrolysis Method
16%
Apoptosis
16%
Microstructure
16%
Adipogenesis
15%
Therapeutic Agents
15%
Drug Toxicity
14%
Ligation
14%
Dendron
14%
Amine nucleophile
14%
One-step Method
14%
3,4-Diaminobenzoic Acid
14%
Chondrogenesis
14%
Statins
13%
Guanidine
13%
Boronic Acid
13%
Crystallite Size
13%
Osteogenic Differentiation
13%
Pharmacology, Toxicology and Pharmaceutical Science
Dendrimer
85%
Poly(amidoamine)
46%
Melamine
33%
Cytotoxicity
27%
Hydroxyapatite
26%
Quinazoline
22%
Simvastatin
16%
Drug Toxicity
14%
Adverse Event
12%
Cuprous Ion
11%
Anabasine
11%
Castration Resistant Prostate Cancer
11%
Surfactant
11%
C Peptide
11%
Bovine Serum Albumin
11%
Green Fluorescent Protein
11%
Inducible Nitric Oxide Synthase
11%
Lactam
11%
Uracil
11%
Crystallization
11%
Nanocomposite
11%
Nuclease
11%
Piperidine
11%
Glycolic Acid
11%
Biocompatibility
11%
Epigallocatechin Gallate
11%
Calcium Pyrophosphate
11%
4 Pyridone Derivative
11%
Calcium Phosphate
11%
Hyaluronic Acid
11%
Quinazoline Derivative
11%
Diketone
11%
2 Aminobenzamide
11%
Statin (Protein)
11%
Boronic Acid Derivative
11%
Cetrimonium Bromide
11%
Hydrazide
11%
Prostate Cancer
11%
Multiple Drug Resistance
11%
Nucleophile
11%
Zebra Fish
11%
Fluorine 18
11%
Calcium Phosphate Dibasic
11%
Peroxisome Proliferator Activated Receptor Gamma
11%
Controlled Release
11%
Bone Defect
11%
Amino Acid
11%
Microsphere
8%
Androgen Receptor
8%
Monomer
8%